FTC Submits Comment on Final Information Blocking Rule
FTC Submits Comment on Final Information Blocking Rule to the Department of Health & Human Services’ Office of the National Coordinator for Health Information Technology.
Read MoreArticles by HHS/ONC/CMS Communications
ONC The Cures Act Final Rule
Today, the Office of the National Coordinator for Health IT (ONC) announced the release of the 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program Final Rule, which implements provisions from the 21st Century Cures Act passed by Congress.
ONC and CMS Release Cures Act Rules
HHS Finalizes Historic Rules to Provide Patients More Control of Their Health Data: Final rules require access to health information, spur innovation and aim to end information blocking.
We’re One in a Million: ONC and the Precision Medicine Initiative
By Teresa Zayas Caban, Kevin Chaney MGS, Stephanie Garcia MPH, Tracy Okubo PMP & Robert Carroll PhD – The increasing availability of electronic health data in the 21st century has tremendous potential to ignite a new era of inquiry and discovery.
Learn More About Medicare Promoting Interoperability Program Requirements for 2020
The final rule adopted policies that will continue the advancement of certified EHR technology (CEHRT) utilization, further reduce burden, and increase interoperability and patient access to their health information.
HHS Proposes New Rules to Improve the Interoperability of Electronic Health Information
New innovations in technology promote patient access and could make no-cost health data exchange a reality for millions. HSS proposed new rules to support seamless and secure access, exchange, and use of electronic health information.
Register and Attest to the 2019 Medicare Promoting Interoperability Program by March 2, 2020
The deadline to submit 2019 data for the Centers for Medicare & Medicaid Services’ (CMS) Medicare Promoting Interoperability Program is March 2, 2020.
CMS Expands Coverage of Next Generation Sequencing as a Diagnostic Tool for Patients with Breast and Ovarian Cancer
(CMS took action to cover FDA approved or cleared laboratory diagnostic tests using Next Generation Sequencing (NGS) for patients with germline (inherited) ovarian or breast cancer.
New 2020 Resources Now Available on the QPP Resource Library
CMS has posted the following new Quality Payment Program (QPP) resources to the QPP Resource Library to help clinicians understand how to participate in QPP in the 2020 performance period: